309 related articles for article (PubMed ID: 11606713)
1. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.
Rodriguez-Manzaneque JC; Lane TF; Ortega MA; Hynes RO; Lawler J; Iruela-Arispe ML
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12485-90. PubMed ID: 11606713
[TBL] [Abstract][Full Text] [Related]
2. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
[TBL] [Abstract][Full Text] [Related]
3. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
4. Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations.
de Fraipont F; El Atifi M; Gicquel C; Bertagna X; Chambaz EM; Feige JJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4734-41. PubMed ID: 11134136
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway.
Nör JE; Mitra RS; Sutorik MM; Mooney DJ; Castle VP; Polverini PJ
J Vasc Res; 2000; 37(3):209-18. PubMed ID: 10859480
[TBL] [Abstract][Full Text] [Related]
6. Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1.
Zhou L; Isenberg JS; Cao Z; Roberts DD
Oncogene; 2006 Jan; 25(4):536-45. PubMed ID: 16247480
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
10. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration.
Wang S; Wu Z; Sorenson CM; Lawler J; Sheibani N
Dev Dyn; 2003 Dec; 228(4):630-42. PubMed ID: 14648840
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.
Yoshiji H; Kuriyama S; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
Clin Cancer Res; 2001 Apr; 7(4):1073-8. PubMed ID: 11309359
[TBL] [Abstract][Full Text] [Related]
15. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins.
Qabar AN; Bullock J; Matej L; Polverini P
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):147-53. PubMed ID: 10657251
[TBL] [Abstract][Full Text] [Related]
19. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
